Correction: Safety and efficacy of nemolizumab for patients with pruritus: a systematic review and meta-regression analysis of randomized controlled trial

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-02-03
DOI
https://doi.org/10.3389/fimmu.2026.1773876
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Safety and efficacy of nemolizumab for patients with pruritus: a systematic review and meta-regression analysis of randomized controlled trial

Yingbing Sang, X. Kang, Yongzhen Hong, Maoli Dan et al.
Frontiers in Immunology
Dermatology and Skin Diseases
article

Correction: Safety and efficacy of nemolizumab for patients with pruritus: a systematic review and meta-regression analysis of randomized controlled trial

Yingbing Sang, X. Kang, Yongzhen Hong, Maoli Dan, J. Liang, Fengxia Hu, Qian Wang, Kailibinuer Abulikemu
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 17
People's Hospital of Xinjiang Uygur Autonomous Region (CN)
Good health and well-being
Openalex Percentile: Top 68%
Dermatology and Skin Diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction: Safety and efficacy of nemolizumab for patients with pruritus: a systematic review and meta-regression analysis of randomized controlled trial — Yingbing Sang, X. Kang, et al. · Frontiers in Immunology (2026) | TGRS Research Map | TGRS